Biotechnology in the Time of COVID-19: Commentaries from the Front Line

by Jeremy M. Levin

Paul Hastings is the chief executive officer of Nkarta, a privately held biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer.